Please use this identifier to cite or link to this item: https://doi.org/10.1002/humu.23234
Title: Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants
Authors: Tio M. 
Wen R.
Lim Y.L.
Zukifli Z.H.B.
Xie S. 
Ho P.
Zhou Z. 
Koh T.-W. 
Zhao Y.
Tan E.-K. 
Keywords: CHCHD2
Drosophila
Parkinson disease
pathogenic variant
risk variant
Issue Date: 2017
Publisher: John Wiley and Sons Inc.
Citation: Tio M., Wen R., Lim Y.L., Zukifli Z.H.B., Xie S., Ho P., Zhou Z., Koh T.-W., Zhao Y., Tan E.-K. (2017). Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants. Human Mutation 38 (8) : 978-987. ScholarBank@NUS Repository. https://doi.org/10.1002/humu.23234
Abstract: Mutations and polymorphic risk variant of coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) have been associated with late-onset Parkinson disease. In vivo pathological evidence of CHCHD2 mutations is currently lacking. Utilizing transgenic Drosophila model, we examined the relative pathophysiologic effect of the pathogenic (c.182C>T, p.Thr61Ile and c.434G>A, p.Arg145Gln) and the risk (c.5C>T, p.Pro2Leu) CHCHD2 variants. All the transgenic models exhibited locomotor dysfunction that could be exacerbated by rotenone exposure, dopaminergic neuron degeneration, reduction in lifespan, mitochondrial dysfunction, oxidative stress, and impairment in synaptic transmission. However, both mutants showed more severe early motor dysfunction, dopaminergic neuronal loss, and higher hydrogen peroxide production compared with the risk variant. p.Thr61Ile (co-segregated in three independent PD families) displayed the most severe phenotype followed by p.Arg145Gln (present only in index patient). We treated the transgenic flies with Ebselen, a mitochondrial hydrogen peroxide scavenger compound; Ebselen appears to be more effective in ameliorating motor function in the mutant than the risk variant models. We provide the first in vivo evidence of the pathological effects associated with CHCHD2 mutations. There was a difference in the pathological and drug response effects between the pathogenic and the risk variants. Ebselen may be a useful neuroprotective drug for carriers of CHCHD2 mutations. � 2017 Wiley Periodicals, Inc.
Source Title: Human Mutation
URI: http://scholarbank.nus.edu.sg/handle/10635/150212
ISSN: 10597794
DOI: 10.1002/humu.23234
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

13
checked on May 5, 2021

WEB OF SCIENCETM
Citations

7
checked on Jul 17, 2019

Page view(s)

42
checked on Apr 30, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.